Medicaloid

Sun Pharmaceutical

Fierce Pharma Asia—Lilly’s COVID-19 antibody results, Asahi Kasei deal; Takeda’s EGFR lung cancer data

Medicaloid
Eli Lilly said its two-drug COVID-19 antibody cocktail could prevent hospitalization or death among high-risk patients. The Indianapolis pharma in-licensed a neuroinflammatory pain candidate from...